# A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis

> **NCT01140503** · NA · TERMINATED · sponsor: **Stanford University** · enrollment: 5 (actual)

## Conditions studied

- Dermatomyositis

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT01140503
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2011-08
- **Final completion:** 2011-09
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Slow recruitment of participants
- **Last updated:** 2015-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140503, "A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01140503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*